{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:17:53Z","timestamp":1790533073996,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cytochrome P450-2E1 (CYP2E1) increases oxidative stress. High hepatic cholesterol causes non-alcoholic steatohepatitis (NASH) and fibrosis. Thus, we aimed to study the role of CYP2E1 in promoting liver fibrosis by high cholesterol-containing fast-food (FF). Male wild-type (WT) and <jats:italic>Cyp2e1<\/jats:italic>-null mice were fed standard chow or FF for 2, 12, and 24 weeks. Various parameters of liver fibrosis and potential mechanisms such as oxidative and endoplasmic reticulum (ER) stress, inflammation, and insulin resistance (IR) were studied. Indirect calorimetry was also used to determine metabolic parameters. Liver histology showed that only WT fed FF (WT-FF) developed NASH and fibrosis. Hepatic levels of fibrosis protein markers were significantly increased in WT-FF. The nitroxidative stress marker iNOS, but not CYP2E1, was significantly elevated only in FF-fed WT. Serum endotoxin, TLR-4 levels, and inflammatory markers were highest in WT-FF. FAS, PPAR-\u03b1, PPAR-\u03b3, and CB1-R were markedly altered in WT-FF. Electron microscopy and immunoblot analyses showed significantly higher levels of ER stress in FF-fed WT. Indirect calorimetry showed that <jats:italic>Cyp2e1<\/jats:italic>-null-mice fed FF exhibited consistently higher total energy expenditure (TEE) than their corresponding WT. These results demonstrate that CYP2E1 is important in fast food-mediated liver fibrosis by promoting nitroxidative and ER stress, endotoxemia, inflammation, IR, and low TEE.<\/jats:p>","DOI":"10.1038\/srep39764","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T10:17:45Z","timestamp":1483525065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Mohamed A.","family":"Abdelmegeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngshim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Godlewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Kwon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atrayee","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehwan","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung-Joon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"key":"BFsrep39764_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917\u2013923, doi: 10.1053\/jhep.2003.50161 (2003).","journal-title":"Hepatology"},{"key":"BFsrep39764_CR2","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51, 1820\u20131832, doi: 10.1002\/hep.23594 (2010).","journal-title":"Hepatology"},{"key":"BFsrep39764_CR3","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.3748\/wjg.v17.i29.3377","volume":"17","author":"S Zelber-Sagi","year":"2011","unstructured":"Zelber-Sagi, S., Ratziu, V. & Oren, R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17, 3377\u20133389, doi: 10.3748\/wjg.v17.i29.3377 (2011).","journal-title":"World J Gastroenterol"},{"key":"BFsrep39764_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day, C. P. & James, O. F. Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114, 842\u2013845 (1998).","journal-title":"Gastroenterology"},{"key":"BFsrep39764_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche, K., Igoudjil, A., Pessayre, D. & Fromenty, B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6, 1\u201328, doi: 10.1016\/j.mito.2005.10.004 (2006).","journal-title":"Mitochondrion"},{"key":"BFsrep39764_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113\u2013121 (2005).","journal-title":"Gastroenterology"},{"key":"BFsrep39764_CR7","doi-asserted-by":"publisher","first-page":"20704","DOI":"10.3390\/ijms141020704","volume":"14","author":"A Takaki","year":"2013","unstructured":"Takaki, A., Kawai, D. & Yamamoto, K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci 14, 20704\u201320728, doi: 10.3390\/ijms141020704 (2013).","journal-title":"Int J Mol Sci"},{"key":"BFsrep39764_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","volume":"48","author":"T Review","year":"2014","unstructured":"Review, T. et al. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 48, 467\u2013473, doi: 10.1097\/MCG.0000000000000116 (2014).","journal-title":"J Clin Gastroenterol"},{"key":"BFsrep39764_CR9","doi-asserted-by":"publisher","first-page":"G9","DOI":"10.1152\/ajpgi.00008.2012","volume":"303","author":"GC Farrell","year":"2012","unstructured":"Farrell, G. C. & van Rooyen, D. Liver cholesterol: is it playing possum in NASH? Am J Physiol Gastrointest Liver Physiol 303, G9\u201311, doi: 10.1152\/ajpgi.00008.2012 (2012).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFsrep39764_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/hep.26604","volume":"59","author":"K Tomita","year":"2014","unstructured":"Tomita, K. et al. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice. Hepatology 59, 154\u2013169, doi: 10.1002\/hep.26604 (2014).","journal-title":"Hepatology"},{"key":"BFsrep39764_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/labinvest.2015.67","volume":"95","author":"S Anavi","year":"2015","unstructured":"Anavi, S. et al. The role of iNOS in cholesterol-induced liver fibrosis. Lab Invest 95, 914\u2013924, doi: 10.1038\/labinvest.2015.67 (2015).","journal-title":"Lab Invest"},{"key":"BFsrep39764_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","volume":"35","author":"J Aubert","year":"2011","unstructured":"Aubert, J., Begriche, K., Knockaert, L., Robin, M. A. & Fromenty, B. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol 35, 630\u2013637, doi: 10.1016\/j.clinre.2011.04.015 (2011).","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"BFsrep39764_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.pharmtox.44.101802.121704","volume":"44","author":"AA Caro","year":"2004","unstructured":"Caro, A. A. & Cederbaum, A. I. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44, 27\u201342, doi: 10.1146\/annurev.pharmtox.44.101802.121704 (2004).","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFsrep39764_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ajcn\/79.3.502","volume":"79","author":"CS Lieber","year":"2004","unstructured":"Lieber, C. S. et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79, 502\u2013509 (2004).","journal-title":"Am J Clin Nutr"},{"key":"BFsrep39764_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3945\/jn.110.135210","volume":"141","author":"MA Abdelmegeed","year":"2011","unstructured":"Abdelmegeed, M. A. et al. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr 141, 603\u2013610, doi: 10.3945\/jn.110.135210 (2011).","journal-title":"J Nutr"},{"key":"BFsrep39764_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","volume":"57","author":"MA Abdelmegeed","year":"2012","unstructured":"Abdelmegeed, M. A. et al. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. J Hepatol 57, 860\u2013866, doi: 10.1016\/j.jhep.2012.05.019 (2012).","journal-title":"J Hepatol"},{"key":"BFsrep39764_CR17","doi-asserted-by":"publisher","first-page":"E532","DOI":"10.1152\/ajpendo.00258.2011","volume":"302","author":"H Zong","year":"2012","unstructured":"Zong, H., Armoni, M., Harel, C., Karnieli, E. & Pessin, J. E. Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab 302, E532\u2013539, doi: 10.1152\/ajpendo.00258.2011 (2012).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFsrep39764_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321, doi: 10.1002\/hep.20701 (2005).","journal-title":"Hepatology"},{"key":"BFsrep39764_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0021-9150(00)00456-1","volume":"151","author":"E Ros","year":"2000","unstructured":"Ros, E. Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis 151, 357\u2013379 (2000).","journal-title":"Atherosclerosis"},{"key":"BFsrep39764_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.bi.52.070183.001255","volume":"52","author":"MS Brown","year":"1983","unstructured":"Brown, M. S. & Goldstein, J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52, 223\u2013261, doi: 10.1146\/annurev.bi.52.070183.001255 (1983).","journal-title":"Annu Rev Biochem"},{"key":"BFsrep39764_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jnutbio.2014.11.002","volume":"26","author":"JE Mells","year":"2015","unstructured":"Mells, J. E. et al. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. J Nutr Biochem 26, 285\u2013292, doi: 10.1016\/j.jnutbio.2014.11.002 (2015).","journal-title":"J Nutr Biochem"},{"key":"BFsrep39764_CR22","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.22222","volume":"47","author":"Y Lu","year":"2008","unstructured":"Lu, Y., Zhuge, J., Wang, X., Bai, J. & Cederbaum, A. I. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 47, 1483\u20131494, doi: 10.1002\/hep.22222 (2008).","journal-title":"Hepatology"},{"key":"BFsrep39764_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1515\/dmdi-2012-0014","volume":"27","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum, A. I. CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment. Drug Metabol Drug Interact 27, 125\u2013144, doi: 10.1515\/dmdi-2012-0014 (2012).","journal-title":"Drug Metabol Drug Interact"},{"key":"BFsrep39764_CR24","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.freeradbiomed.2013.09.009","volume":"65","author":"MA Abdelmegeed","year":"2013","unstructured":"Abdelmegeed, M. A. et al. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med 65, 1238\u20131245, doi: 10.1016\/j.freeradbiomed.2013.09.009 (2013).","journal-title":"Free Radic Biol Med"},{"key":"BFsrep39764_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","volume":"1821","author":"A Tailleux","year":"2012","unstructured":"Tailleux, A., Wouters, K. & Staels, B. Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 1821, 809\u2013818, doi: 10.1016\/j.bbalip.2011.10.016 (2012).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep39764_CR26","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1172\/JCI34827","volume":"118","author":"D Osei-Hyiaman","year":"2008","unstructured":"Osei-Hyiaman, D. et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118, 3160\u20133169, doi: 10.1172\/JCI34827 (2008).","journal-title":"J Clin Invest"},{"key":"BFsrep39764_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000444556","volume":"34","author":"R Weiskirchen","year":"2016","unstructured":"Weiskirchen, R. & Tacke, F. Liver Fibrosis: From Pathogenesis to Novel Therapies. Dig Dis 34, 410\u2013422, doi: 10.1159\/000444556 (2016).","journal-title":"Dig Dis"},{"key":"BFsrep39764_CR28","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ajpath.2012.01.025","volume":"180","author":"S Jeong","year":"2012","unstructured":"Jeong, S. et al. Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. Am J Pathol 180, 2028\u20132039, doi: 10.1016\/j.ajpath.2012.01.025 (2012).","journal-title":"Am J Pathol"},{"key":"BFsrep39764_CR29","doi-asserted-by":"publisher","first-page":"12928","DOI":"10.1074\/jbc.M700554200","volume":"282","author":"YP Han","year":"2007","unstructured":"Han, Y. P., Yan, C., Zhou, L., Qin, L. & Tsukamoto, H. A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix. J Biol Chem 282, 12928\u201312939, doi: 10.1074\/jbc.M700554200 (2007).","journal-title":"J Biol Chem"},{"key":"BFsrep39764_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0168-8278(98)80251-1","volume":"29","author":"H Tsukada","year":"1998","unstructured":"Tsukada, H. et al. Dietary carbohydrate intake plays an important role in preventing alcoholic fatty liver in the rat. J Hepatol 29, 715\u2013724 (1998).","journal-title":"J Hepatol"},{"key":"BFsrep39764_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/toxsci\/47.1.110","volume":"47","author":"S Korourian","year":"1999","unstructured":"Korourian, S. et al. Diet and risk of ethanol-induced hepatotoxicity: carbohydrate-fat relationships in rats. Toxicol Sci 47, 110\u2013117 (1999).","journal-title":"Toxicol Sci"},{"key":"BFsrep39764_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-015-1172-8","volume":"389","author":"F Hong","year":"2016","unstructured":"Hong, F. et al. The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. Naunyn Schmiedebergs Arch Pharmacol 389, 33\u201343, doi: 10.1007\/s00210-015-1172-8 (2016).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFsrep39764_CR33","doi-asserted-by":"publisher","first-page":"e87336","DOI":"10.1172\/jci.insight.87336","volume":"1","author":"R Cinar","year":"2016","unstructured":"Cinar, R., L., M., Liu, Z., Cao, Z., Jourdan, T., Erdelyi, K. et al. Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis. JCI Insight. 1, e87336\u201387355 (2016).","journal-title":"JCI Insight"},{"key":"BFsrep39764_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-94-007-5881-0_5","volume":"67","author":"AK Daly","year":"2013","unstructured":"Daly, A. K. Relevance of CYP2E1 to non-alcoholic fatty liver disease. Subcell Biochem 67, 165\u2013175, doi: 10.1007\/978-94-007-5881-0_5 (2013).","journal-title":"Subcell Biochem"},{"key":"BFsrep39764_CR35","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/hep.22087","volume":"47","author":"D Wu","year":"2008","unstructured":"Wu, D. & Cederbaum, A. Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice. Hepatology 47, 1005\u20131017, doi: 10.1002\/hep.22087 (2008).","journal-title":"Hepatology"},{"key":"BFsrep39764_CR36","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/mmr.2014.2995","volume":"11","author":"A Douhara","year":"2015","unstructured":"Douhara, A. et al. Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. Mol Med Rep 11, 1693\u20131700, doi: 10.3892\/mmr.2014.2995 (2015).","journal-title":"Mol Med Rep"},{"key":"BFsrep39764_CR37","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1136\/gutjnl-2013-306484","volume":"64","author":"JD Coombes","year":"2015","unstructured":"Coombes, J. D. et al. Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice. Gut 64, 1120\u20131131, doi: 10.1136\/gutjnl-2013-306484 (2015).","journal-title":"Gut"},{"key":"BFsrep39764_CR38","doi-asserted-by":"publisher","first-page":"G264","DOI":"10.1152\/ajpgi.00002.2004","volume":"287","author":"A Sahai","year":"2004","unstructured":"Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M. & Whitington, P. F. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287, G264\u2013273, doi: 10.1152\/ajpgi.00002.2004 (2004).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFsrep39764_CR39","doi-asserted-by":"publisher","first-page":"G1035","DOI":"10.1152\/ajpgi.00199.2004","volume":"287","author":"A Sahai","year":"2004","unstructured":"Sahai, A. et al. Obese and diabetic db\/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287, G1035\u20131043, doi: 10.1152\/ajpgi.00199.2004 (2004).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFsrep39764_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/toxsci\/kft104","volume":"134","author":"RK Seth","year":"2013","unstructured":"Seth, R. K. et al. Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice. Toxicol Sci 134, 291\u2013303, doi: 10.1093\/toxsci\/kft104 (2013).","journal-title":"Toxicol Sci"},{"key":"BFsrep39764_CR41","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","volume":"140","author":"GS Hotamisligil","year":"2010","unstructured":"Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900\u2013917, doi: 10.1016\/j.cell.2010.02.034 (2010).","journal-title":"Cell"},{"key":"BFsrep39764_CR42","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","volume":"5","author":"V Zambo","year":"2013","unstructured":"Zambo, V. et al. Lipotoxicity in the liver. World J Hepatol 5, 550\u2013557, doi: 10.4254\/wjh.v5.i10.550 (2013).","journal-title":"World J Hepatol"},{"key":"BFsrep39764_CR43","doi-asserted-by":"publisher","first-page":"20848","DOI":"10.1038\/srep20848","volume":"6","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Sci Rep 6, 20848, doi: 10.1038\/srep20848 (2016).","journal-title":"Sci Rep"},{"key":"BFsrep39764_CR44","doi-asserted-by":"publisher","first-page":"9887","DOI":"10.1074\/jbc.M410310200","volume":"280","author":"JM Schattenberg","year":"2005","unstructured":"Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M. & Czaja, M. J. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem 280, 9887\u20139894, doi: 10.1074\/jbc.M410310200 (2005).","journal-title":"J Biol Chem"},{"key":"BFsrep39764_CR45","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/MEG.0b013e328328f461","volume":"21","author":"E Kathirvel","year":"2009","unstructured":"Kathirvel, E., Morgan, K., French, S. W. & Morgan, T. R. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 21, 973\u2013983, doi: 10.1097\/MEG.0b013e328328f461 (2009).","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFsrep39764_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2015.12.016","volume":"91","author":"MA Abdelmegeed","year":"2016","unstructured":"Abdelmegeed, M. A., Choi, Y., Ha, S. K. & Song, B. J. Cytochrome P450-2E1 promotes aging-related hepatic steatosis, apoptosis and fibrosis through increased nitroxidative stress. Free Radic Biol Med 91, 188\u2013202, doi: 10.1016\/j.freeradbiomed.2015.12.016 (2016).","journal-title":"Free Radic Biol Med"},{"key":"BFsrep39764_CR47","doi-asserted-by":"publisher","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","volume":"271","author":"SS Lee","year":"1996","unstructured":"Lee, S. S., Buters, J. T., Pineau, T., Fernandez-Salguero, P. & Gonzalez, F. J. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271, 12063\u201312067 (1996).","journal-title":"J Biol Chem"}],"updated-by":[{"DOI":"10.1038\/srep42566","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep39764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39764","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:02:12Z","timestamp":1671843732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep39764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,2,8]]}},"alternative-id":["BFsrep39764"],"URL":"https:\/\/doi.org\/10.1038\/srep39764","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,4]]},"assertion":[{"value":"3 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2017","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39764"}}